Related Experiment Video

Updated: May 13, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2

Mitsuhiro Matsuo1, Chisato Nakada, Yoshiyuki Tsukamoto

  • 1Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.

Molecular Cancer
|February 28, 2013
PubMed
Abstract

Insights

MicroRNA-29c (miR-29c) acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation. Its downregulation in gastric carcinoma is linked to increased expression of RCC2, promoting tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-29c (miR-29c) is downregulated in advanced gastric carcinoma.
  • This study investigates the tumor-suppressive role of miR-29c in gastric cancer cells.

Purpose of the Study:

  • To verify miR-29c downregulation in gastric carcinoma tissues.
  • To assess the biological effects of miR-29c on gastric carcinoma cell behavior.
  • To elucidate the molecular mechanisms underlying miR-29c's function.

Main Methods:

  • MiRNA microarray analysis to identify differentially expressed genes.
  • Cell transfection with miR-29c mimics and siRNAs.
  • Assessment of cell proliferation, colony formation, apoptosis, and BrdU incorporation.
  • Validation of target genes (RCC2, PPIC, CDK6) using 3'-UTR luciferase assays and Western blotting.

Main Results:

  • Overexpression of miR-29c significantly reduced gastric cancer cell proliferation and colony formation.
  • miR-29c downregulation was confirmed in gastric carcinoma tissues.
  • RCC2 and PPIC were identified as direct targets of miR-29c, with RCC2 upregulation in tumors.
  • Knockdown of RCC2 mimicked the anti-proliferative effects of miR-29c, suggesting its role in miR-29c-mediated growth suppression.

Conclusions:

  • miR-29c exhibits tumor-suppressive functions in gastric carcinoma.
  • Downregulation of miR-29c contributes to gastric tumor growth by upregulating RCC2.
  • miR-29c represents a potential therapeutic target for gastric cancer.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...